A drug for autoimmune disease Sjögren's syndrome, picked up by Novartis when it bought MorphoSys for $2.9 billion last year, has hit the target in a pair of phase 3 trials. Ianalumab (VAY736), a drug ...

Raised in London and Accra, Baff Akoto is an artist working across multiple mediums. A self-taught filmmaker, Baff is interested in the fluidity of visual grammar and characters who wrestle with ...

Studies of mouse models of lupus provided the rationale for targeting BAFF in the treatment of patients with systemic lupus erythematosus, and could also help explain why individuals might differ in ...

If my makeup routine has five steps, one of them is always lip gloss. If it’s pared down to three steps, it's still a non-negotiable. And if I had to choose just one must-have product? You guessed ...

Cancer remains a leading cause of death in industrialized countries 1. Although mortality rates have declined in recent years owing to earlier detection and the availability of new treatments options, ...